Savings From Comparative Effectiveness Entity Could Be Decade Away – CBO
This article was originally published in The Gray Sheet
Executive Summary
Expansion of medical product comparative effectiveness research may not yield cost savings for 10 years, according to Congressional Budget Office Director Peter Orszag